OPDIVO 10 mg/mL

OPDIVO 10 mg/mL is an intravenous injection containing nivolumab, used for various medical conditions. This single-dose vial is manufactured by E.R. Squibb & Sons, L.L.C. in the USA.

OPDIVO 10 mg/mL is a medication that contains the active ingredient nivolumab. It is commonly used in the treatment of certain types of cancer, including melanoma, lung cancer, and renal cell carcinoma. Nivolumab works by helping the immune system to fight cancer cells. It is often prescribed by healthcare professionals as part of a comprehensive treatment plan.

Common effects of OPDIVO 10 mg/mL may include fatigue, nausea, and skin reactions. Some patients may experience more severe side effects, such as immune-related adverse events. It is important to discuss any concerns with a healthcare provider.

OPDIVO 10 mg/mL should be handled with care and administered by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment.

OPDIVO 10 mg/mL may interact with other medications, including immunosuppressants and certain cancer treatments. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.